VYNE Therapeutics Inc. (VYNE) earnings

VYNE earnings moved a median of +0.94% by the close. Quarterly and annual VYNE reports and results, each read against the price at its own news timestamp. Back to the VYNE overview →

13 measured VYNE earnings events.

Where these VYNE earnings landedvs 13 measured VYNE earnings reactions
VYNE earningsMiddle 50% · 0.00% to +2.37%Zero: 0.00%Median: +0.94%Median +0.94%-3.00%0+3.00%
Middle 50% of VYNE earnings reactions0.00% to +2.37%
Median reaction (to close)+0.94%
Measured reactions13
Point-in-time · zero look-ahead

Half of the 13 VYNE earnings events with a measured close landed between +0.00% and +2.37%; 69% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q VYNE Therapeutics Inc. For: Mar 31SEC filing · Form 10-Q+0.39%+0.94%
Form 10-K VYNE Therapeutics Inc. For: Dec 31SEC filing · Form 10-K-3.53%+1.44%
Form 10-Q VYNE Therapeutics Inc. For: Sep 30SEC filing · Form 10-Q+0.67%-2.14%
Form 10-Q VYNE Therapeutics Inc. For: Jun 30SEC filing · Form 10-Q+2.91%+3.18%
Form 10-Q VYNE Therapeutics Inc. For: Mar 31SEC filing · Form 10-Q+1.57%+2.36%
Form 10-K VYNE Therapeutics Inc. For: Dec 31SEC filing · Form 10-K+0.00%-3.52%
Form 10-Q VYNE Therapeutics Inc. For: Sep 30SEC filing · Form 10-Q+0.64%+0.32%
VYNE Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdatePress release+1.78%+0.80%
Form 10-Q VYNE Therapeutics Inc. For: Jun 30SEC filing · Form 10-Q+0.58%+7.51%
VYNE Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdatePress release+0.00%+2.37%
Form 10-Q VYNE Therapeutics Inc. For: Mar 31SEC filing · Form 10-Q+3.37%+0.00%
VYNE Reports First Quarter 2024 Financial Results and Provides Business UpdatePress release+0.00%-4.33%
Form 10-K VYNE Therapeutics Inc. For: Dec 31SEC filing · Form 10-K+2.38%+8.57%
That’s how VYNE usually reacts to earnings — get an email when it moves on news →
Keep exploring

More VYNE: analyst actions → · SEC filings → · VYNE overview →